Contributions
Stay tuned—this is where the team’s scientific contributions will be shared.
Accolades
Check back soon to see how this team is being recognized.
Cognitive dysfunction significantly reduces quality of life for Parkinson’s patients and caretakers. We show that cognitive symptoms are controlled by ventral tegmental area (VTA) dopamine neurons, a genetically-defined subset of which degrades in Parkinson’s Disease (PD). Glutamate-dopamine co transmitting neurons preferentially survive in PD over nonglutamate-dopamine neurons. We hypothesize that VTA dopamine cell-type imbalance causes cognitive dysfunction. We will identify how surviving genetically-distinct VTA dopaminergic cell-types and targets are altered physiologically, transcriptionally, and functionally in their processing of cognitive information, as well as how they may be leveraged to reduce PD cognitive symptoms.
Members of the CRN work diligently to advance our understanding of Parkinson’s disease. Learn more about recent CRN discoveries and achievements.